Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.

Moutzouri E, Liberopoulos EN, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS.

Atherosclerosis. 2013 Nov;231(1):8-14. doi: 10.1016/j.atherosclerosis.2013.08.013. Epub 2013 Aug 27.

PMID:
24125402
2.

The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.

Tellis CC, Moutzouri E, Elisaf M, Wolfert RL, Tselepis AD.

J Lipid Res. 2013 Dec;54(12):3394-402. doi: 10.1194/jlr.M041806. Epub 2013 Oct 3.

3.

Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.

Vlahos AP, Naka KK, Bechlioulis A, Theoharis P, Vakalis K, Moutzouri E, Miltiadous G, Michalis LK, Siamopoulou-Mavridou A, Elisaf M, Milionis HJ.

Pediatr Cardiol. 2014 Jan;35(1):63-70. doi: 10.1007/s00246-013-0742-0. Epub 2013 Jul 3.

PMID:
23821294
4.

Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels.

Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M.

J Cardiovasc Pharmacol Ther. 2013 May;18(3):229-33. doi: 10.1177/1074248412470513. Epub 2013 Jan 2.

PMID:
23288870
5.

Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.

Moutzouri E, Tsimihodimos V, Tselepis AD.

Curr Pharm Des. 2013;19(21):3827-40. Review.

PMID:
23286437
6.

Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.

Liberopoulos EN, Moutzouri E, Rizos CV, Barkas F, Liamis G, Elisaf MS.

J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):113-8. doi: 10.1177/1074248412463611. Epub 2012 Oct 31.

PMID:
23113965
7.

Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.

Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, Tselepis AD.

Atherosclerosis. 2012 Dec;225(2):381-7. doi: 10.1016/j.atherosclerosis.2012.08.037. Epub 2012 Sep 24.

PMID:
23062767
8.

Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.

Moutzouri E, Liberopoulos EN, Florentin M, Liamis G, Elisaf MS.

J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):13-8. doi: 10.1177/1074248412444463. Epub 2012 Apr 26.

PMID:
22539817
9.

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice.

Moutzouri E, Liberopoulos EN, Elisaf M.

Arch Med Sci. 2011 Aug;7(4):736-9. doi: 10.5114/aoms.2011.24148. Epub 2011 Sep 2.

10.

Prediabetes: to treat or not to treat?

Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M.

Eur J Pharmacol. 2011 Dec 15;672(1-3):9-19. doi: 10.1016/j.ejphar.2011.10.007. Epub 2011 Oct 12. Review.

PMID:
22020287
11.

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

Moutzouri E, Liberopoulos E, Mikhailidis DP, Kostapanos MS, Kei AA, Milionis H, Elisaf M.

Int J Clin Pract. 2011 Nov;65(11):1141-8. doi: 10.1111/j.1742-1241.2011.02779.x.

PMID:
21995692
12.

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study.

Kei A, Elisaf M, Moutzouri E, Tsiara S, Liberopoulos E.

Int J Hypertens. 2011;2011:830434. doi: 10.4061/2011/830434. Epub 2011 May 15.

13.

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.

Florentin M, Liberopoulos EN, Moutzouri E, Rizos CV, Tselepis AD, Elisaf MS.

Curr Med Res Opin. 2011 Mar;27(3):685-92. doi: 10.1185/03007995.2010.546394. Epub 2011 Jan 27.

PMID:
21271793
14.

Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidence.

Moutzouri E, Daios G, Elisaf M, Milionis HJ.

CNS Spectr. 2010 Nov;15(11):619-29. doi: 10.1017/S1092852912000077.

PMID:
24726049
15.

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.

Moutzouri E, Kei A, Elisaf MS, Milionis HJ.

Vasc Health Risk Manag. 2010 Aug 9;6:525-39. Review.

16.

Hypocholesterolemia.

Moutzouri E, Elisaf M, Liberopoulos EN.

Curr Vasc Pharmacol. 2011 Mar;9(2):200-12.

PMID:
20626336
17.

Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.

Moutzouri E, Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN.

Curr Vasc Pharmacol. 2010 May;8(3):344-62. Review.

PMID:
20180771
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk